Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.43 |
| ▸ | VCAM1 | P19320 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 6/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | MMP3 | P08254 | 5/20 | 0.38 |
| ▸ | MMP1 | P03956 | 3/20 | 0.38 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.38 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.38 |
| ▸ | MMP7 | P09237 | 1/20 | 0.38 |
| ▸ | F2R | P25116 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | CACNA1A | O00555 | 1/20 | 0.37 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.37 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8076475 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL5415842 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL17491252 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL17491247 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL283576 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL17491327 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL76094 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL17491202 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL17491362 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 | |
| SCHEMBL992239 | 1.00 | GPR84 (0.43) | GPR84VCAM1LMNARECQLMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116496158-A | Preparation method of 3, 5-di-tert-butyl-4-hydroxy benzene propionic acid isomeric tridecyl alcohol ester | 天津利安隆新材料股份有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-112552430-B | Preparation method of hindered phenol antioxidant with high relative molecular weight | 万华化学集团股份有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-112552430-A | Preparation method of hindered phenol antioxidant with high relative molecular weight | 万华化学集团股份有限公司 | 2021-03-26 | — | — | CN | claimed |
| EP-3143086-B1 | STABILISED RESIN COMPOSITION | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2018-10-10 | — | — | EP | claimed |
| US-20170088689-A1 | STABILISED RESIN COMPOSITION | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-03-30 | — | — | US | claimed |
| US-12570920-B2 | Lubricating oil composition, lubrication method, and transmission | IDEMITSU KOSAN CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20250290005-A1 | LUBRICATING OIL COMPOSITION, LUBRICATION METHOD, AND TRANSMISSION | IDEMITSU KOSAN CO.,LTD. (JP) | 2025-09-18 | — | — | US | disclosed |
| US-12338408-B2 | Lubricating oil composition | ENEOS CORPORATION (JP) | 2025-06-24 | — | — | US | disclosed |
| EP-4520808-A1 | LUBRICATING OIL COMPOSITION, LUBRICATION METHOD, AND TRANSMISSION | Idemitsu Kosan Co.,Ltd. (JP) | 2025-03-12 | — | — | EP | disclosed |
| EP-3878929-B1 | LUBRICANT COMPOSITION | ENEOS CORP (JP) | 2025-01-01 | — | — | EP | disclosed |
| EP-3878930-B1 | LUBRICATING OIL COMPOSITION | ENEOS CORP (JP) | 2024-07-31 | — | — | EP | disclosed |
| US-20240186044-A1 | MAGNETO RHEOLOGICAL FLUID AND MAGNETO RHEOLOGICAL FLUID DEVICE | FUJIFILM CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| US-6642189-B2 | Blend of specific base oil with specific amount of polymethacrylate-based viscosity index improver; reduced in viscosity, provides excellent fuel efficiency and low temperature viscosity with less evaporation loss | NIPPON MITSUBISHI OIL CORPORATION (JP) | 2003-11-04 | — | — | US | disclosed |
| US-20030162673-A1 | Engine oil compositions | NIPPON MITSUBISHI OIL CORPORATION | 2003-08-28 | — | — | US | disclosed |
| US-20020142922-A1 | Lubricating oil compositions | NIPPON MITSUBISHI OIL CORPORATION | 2002-10-03 | — | — | US | disclosed |
| EP-1227145-A1 | Lubricating oil compositions | Nippon Mitsubishi Oil Corporation (JP) | 2002-07-31 | — | — | EP | disclosed |
| EP-1111028-A9 | Engine oil composition | Nippon Mitsubishi Oil Corporation (JP) | 2001-12-19 | — | — | EP | disclosed |
| US-20010027169-A1 | Engine oil composition | NIPPON MITSUBISHI OIL CORPORATION | 2001-10-04 | — | — | US | disclosed |
| EP-1111028-A1 | Engine oil composition | Nippon Mitsubishi Oil Corporation (JP) | 2001-06-27 | — | — | EP | disclosed |
| US-5744430-A | BASE OIL, CALCIUM SALICYLATE DETERGENT, A ZINC DIALKYLDITHIOPHOSPHATE, A SUCCINIMIDE DISPERSANT, A PHENOL ANTIOXIDANT, MOLYBDENUM DITHIOCARBAMATE FRICTION MODIFIER, AND VISCOSITY INDEX IMPROVER | NIPPON OIL CO., LTD. (JP) | 1998-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570920-B2 | Lubricating oil composition, lubrication method, and transmission | JAK3, TPM3, JAK1 | GPR84 214/4885VCAM1 3771/4885LMNA 4721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.